Background
==========

Balance is usually defined as preservation of the vertical projection of the body's center of mass (COM) onto the support area that is formed by the feet \[[@B1]\]. Human balance is typically modeled as an inverted pendulum, in which the body is controlled as a single rigid segment that supports a single mass point---the COM---which rotates around the ankle joint \[[@B2]\]. The inverted pendulum is regulated through the development of ground-reaction forces, the vector sum of which is applied to a point that is defined as the vertical projection of the COM onto the ground \[[@B3]\]: the center of pressure (COP).

The body's equilibrium is maintained by the central nervous system, which fixes the COM around a specific point---a goal that is under constant challenge by continuous perturbations to the COM by factors, such as breathing, heart rate, and muscle activity \[[@B4]\]. To maintain postural stability, several afferent inputs, such as visual, vestibular, and somatosensory, are integrated and converted into efferent motor outputs, which in turn are transmitted down to the spinal cord along various motor tracts \[[@B5]\]. Postural sway, such as spontaneous shifts in the COP during quiet standing, represents the integrated output of complex interactions between systems \[[@B6]\]. Damage to any of these systems can result in postural instability, affecting static and dynamic balance---ie, stance and gait \[[@B7]\]. Of the postural control systems, the spinal centers have a significant function, explaining the clinical relevance of postural control deficits in spinal cord injury (SCI) \[[@B8],[@B9]\].

Despite the availability of many technical instruments to assess balance, the most common clinical tools remain observational scales, such as the Tinetti \[[@B10]\] and Berg balance scales \[[@B11]\]. Nevertheless, these scales are hampered by a lack of sensitivity and objectivity and are limited by floor-ceiling effects \[[@B11],[@B12]\].

To overcome these drawbacks, stabilometric platforms (SPs), consisting of a rigid plate that is supported by force transducers, and COP analyses have been introduced in clinical settings \[[@B6]\]. Many studies have reported the use of various SPs to evaluate balance deficits in healthy subjects \[[@B13]\] and in several pathologies, including orthopedic diseases \[[@B14]\], neuropathic lesions \[[@B15]\], essential tremor \[[@B16]\], Parkinson disease \[[@B15]\], multiple sclerosis \[[@B17]\], muscular dystrophy \[[@B18]\], cerebral palsy \[[@B19]\], cerebellar ataxia \[[@B20]\], and stroke \[[@B21]\]. Two recent studies assessed balance in SCI, examining recoveries after visual biofeedback rehabilitation by COP analysis \[[@B8],[@B9]\]. Impaired balance is a significant limitation to overground ambulation in patients with SCI \[[@B11]\], and impairments in balance are predictive of gait recovery \[[@B22]\], thus meriting evaluation \[[@B9]\].

Despite the growing interest in balance, the standardization of COP parameters with regard to measurements and the related quality domains \[[@B23],[@B24]\] (ie, reliability, validity, and responsiveness) \[[@B25]\] is poor \[[@B26]\] and is absent from the SCI population. COP measurements have been examined in healthy elderly individuals \[[@B6],[@B27]\] and in patients with Parkinson \[[@B28]\] and orthopedic diseases \[[@B29]\]. Data from healthy subjects can inflate the reliability estimates, because measurements can be made in them more easily than in patients \[[@B6]\].

Measurement errors, and hence the reliability of a measure, are not fixed but depend on the study population \[[@B30]\] and can vary between test conditions \[[@B6]\]. Thus, measurement properties must be specified for a study population and test conditions.

No study has examined the properties of COP parameters by SP in subjects with SCI. Our serial cross-sectional study aimed to determine the reliability, validity, and responsiveness of COP parameters under various test conditions and define the protocol parameters that are suitable for specifically assessing balance in subjects with incomplete motor SCI.

Methods
=======

Population
----------

This serial cross-sectional study included 23 subjects with incomplete motor SCI. The inclusion criteria comprised traumatic and nontraumatic etiology, subacute and chronic AIS D SCI, and the ability to maintain a standing position unsupported for at least 52 s. The exclusion criteria were the presence of cognitive impairments and any orthopedic or neurological pathology that could influence the assessment of balance. Neurological status was scored per American Spinal Injury Association (ASIA) standards, including the Impairment Scale (AIS) \[[@B31]\]. Patients' demographics, lesion levels, and etiologies are reported in Table [1](#T1){ref-type="table"}.

###### 

Patients' clinical and epidemiological features

                             **Age**        **Gender**      **Weight**        **Height**        **Aethiology**     **Lesion level**   **Time since lesion (months)**   **OF-OE**   **OF-CE**   **CF-OE**   **CF-CE**
  --------------------- ----------------- -------------- ---------------- ------------------ -------------------- ------------------ -------------------------------- ----------- ----------- ----------- -----------
        **PT1\***              19               M               62               173                  T                   T7                        6                      Y           Y           N           N
        **PT2\***              34               F               68               175          NT (Inflammatory)           C5                        24                     Y           Y           Y           Y
        **PT3\***              66               M               74               167          NT (Degenerative)          T11                        15                     Y           Y           Y           Y
         **PT4**               37               M               64               171                  T                   C6                        13                     Y           Y           Y           Y
        **PT5\***              52               M               68               169            NT (Vascular)            T12                        10                     Y           Y           Y           Y
        **PT6\***              33               F               55               167                  T                  T11                        8                      Y           Y           N           N
        **PT7\***              34               F               60               176            NT (Vascular)             T8                        6                      Y           Y           Y           Y
        **PT8\***              54               F               70               168          NT (Degenerative)           L5                        32                     Y           Y           Y           N
        **PT9\***              35               F               66               172          NT (Degenerative)           L4                        8                      Y           N           Y           N
        **PT10**               41               M               88               177                  T                   L3                        5                      Y           Y           N           N
       **PT11\***              64               M               78               160          NT (Inflammatory)           T5                        13                     Y           Y           N           N
        **PT12**               84               M               53               165          NT (Inflammatory)           L1                        8                      Y           Y           N           N
        **PT13**               52               M               80               173          NT (Degenerative)           C7                        8                      Y           Y           Y           Y
       **PT14\***              30               M               65               173                  T                   L3                        9                      Y           Y           Y           Y
        **PT15**               40               M               73               178                  T                   L3                        6                      Y           Y           Y           Y
       **PT16\***              29               M               65               181                  T                  T10                        8                      Y           N           N           N
       **PT17\***              61               F               80               159          NT (Inflammatory)           T7                        14                     Y           N           N           N
       **PT18\***              33               F               85               182                  T                   C6                        8                      Y           Y           Y           Y
       **PT19\***              59               F               60               158          NT (Degenerative)           C5                        72                     Y           Y           Y           Y
       **PT20\***              69               M               75               165                  T                   C5                        13                     Y           Y           Y           Y
       **PT21\***              44               F               57               178          NT (Degenerative)           D1                        75                     Y           Y           Y           Y
       **PT22\***              51               M               74               173                  NT                  C7                        9                      Y           Y           Y           Y
        **PT23**               60               M               65               170          NT (Degenerative)           C7                        8                      Y           Y           Y           Y
   ***Medium (s.d.)***   *48,27 (15,94)*   *14 M - 9 F*   *69,22 (9,37)*   *163,45 (32,65)*   *60.9% NT 39.1% T*                             *16.43 (19,03)*                                                    

T: traumatic lesion; NT: nontraumatic lesion; Lesion level: C: cervical; T: thoracic; L: lumbar. Sensory test conditions: OF: open feet; CF: closed feet; OE: open eyes; CE: closed eyes; Y: assessment performed; N: assessment not performed.\*Patients with SCI who underwent at least 2 consecutive balance assessments, both clinical and instrumental.

Enrolled patients were assessed repeatedly. Specifically, 6 patients were evaluated once, and the remaining 17 patients were assessed 2 to 12 times for 1 year, with 2 weeks between sessions. Overall, 111 evaluation sessions were analyzed, all of which administered clinical and instrument-based assessments of balance. The local ethics committee approved this study (Prot. CE/AG.4-PROG.231-65), and all patients gave informed consent for participation.

Clinical assessment of balance
------------------------------

For each evaluation, the Berg Balance scale (BBS) and Tinetti scale (TS) were used to assess balance clinically, and the Walking Index for Spinal Cord Injury (WISCI) \[[@B32]\] was used to determine the functional level of ambulation. The BBS is a 14-item task-oriented test that was validated recently in SCI patients \[[@B11]\] and can be considered a reflection of functional activity. Total scores range from 0 to 56, with higher scores indicating greater balance and functional independence. The TS includes subscores for equilibrium (TS~E~) and locomotion (TS~L~) \[[@B10]\]. Fourteen items on this clinical test measure balance characteristics (scored out of 24), and 10 items examine gait features (scored out of 16), for a total score of 40, with higher scores indicating greater balance. The WISCI has been validated specifically with regard to gait in subjects with SCI \[[@B33]\]. Total scores range from 0 to 20, with higher scores reflecting greater independent locomotion \[[@B32]\].

Instrument-based stabilometric assessment of balance
----------------------------------------------------

Stabilometric parameters were analyzed using a 320-cm by 75-cm (length x width) static force platform (Platform BPM 120, Physical Support Italia, Italy). The signals were amplified and acquired using dedicated software (Physical gait Software Vv. 2.66, Physical Support Italia, Italy). In assessing static stability, patients stood barefoot in a natural and relaxed position with their arms by their sides and with both heels lined up \[[@B6]\], under 2 sensory conditions: eyes open and facing a target 1.5 m away (OE) and eyes closed (CE).

The feet were placed with the forefoot open 30 degrees and the heels in 2 positions: together (FT) or apart at a comfortable distance (FA). For the FA condition, heel distance (HD) was measured manually by the operator and fixed for the FA-OE and FA-CE conditions and during the recordings. For each evaluation, 4 conditions (FT-OE, FT-CE, FA-OE, and FA-CE) were tested. Under each condition, measures were recorded 3 times, per Ruhe \[[@B6]\]. We selected 51.2 s as the testing time, per the platform manufacturer and other studies \[[@B9],[@B34],[@B35]\]. A slight pause was permitted between recordings to allow the arms to rest on bars, during which the patients were asked to maintain their foot position on the platform. During the data collection, subjects were asked to "stand as still as possible" while looking straight ahead, per Zok et al. \[[@B36]\].

We considered the following quantitative COP parameters:

-- Length indicators: path length (L, mm), mean velocity (V, L divided by the trial duration), anteroposterior (V~AP~) and laterolateral (V~LL~) velocities (mm/s), and mean position of COP along the planar laterolateral (X) and anteroposterior (Y) coordinates on the platform (mm).

-- Surface indicators: area of the ellipse encompassing 90% of COP samples (A, cm^2^) and length of its semiaxes (SA~1~, SA~2~, cm).

Data analysis
-------------

### Demographic features

The influence of demographic features on COP parameters was analyzed using the Spearman correlation coefficient (ρ), applied to data from the first session of each subject.

### Measurement of COP parameters between test conditions

The *reliability* domain contains various measures for continuous data \[[@B23]\]: test-retest and intrarater reliability, measurement error, and minimal detectable change.

$$\left. \%\mathit{MD}\mathit{C}_{95} = \left( {\mathit{MD}\mathit{C}_{95}*100} \right)/\mathit{baseline}\ \mathit{assessment}\ \mathit{value}. \right.$$

1\. *Test-retest reliability,* or *repeatability,* reflects the reliability between tests by the same operator in the same session. Test-retest reliability was assessed using the coefficient of variation (CV). CV is a measure of data dispersion and was the standard deviation that was computed for the values in the 3 recordings, expressed as a percentage of the mean value. Because the ideal mean for planar coordinates is 0, CV was not computed for the Y or X COP.

2\. *Intrarater reliability* determines the reliability across the time of evaluations by the same operator. For continuous data, intraclass correlation (ICC) is the preferred method \[[@B23]\], because it also takes systematic errors between repeated measurements into account. Of the various methods of calculating ICC, consistent with the Shrout and Fleiss reliability coefficients guidelines \[[@B37]\], we adopted the ICC(3,1) form. We analyzed the ICC, with a confidence interval (CI) of 95%, for patients who underwent at least 2 consecutive (within 15 days) assessments (17 subjects).

3\. *Measurement error* indicates the absolute error in measurement and was calculated as the standard error of measurement (SEM) \[[@B23]\]. SEM represents the standard deviation of repeated measures of the same subject (ie, within-subject variability) by the same operator (ie, within-rater variability) and is expressed in units of the measurement tool---in this case, SEM = SD \* √ (1-ICC).

4\. *Minimal detectable change* (MDC~95~) addresses the common problem of deciding whether results are significant or due to errors in measurement. MDC~95~ is defined as the minimal amount of change that is not due to the variation in measurement \[[@B38]\]. Calculated as SEM \*1.65 \* √2, MDC~95~ determines the magnitude of change that exceeds the threshold of measurement error at a 95% confidence level. A 95% confidence interval, as with SEM, increases the precision of score estimates \[[@B38]\]. Further, the percentage of MDC~95~ that indicates the percentage of the minimal amount by which the results change versus baseline---not due to variations in measurement---is calculated per the following formula:

Reliability assessments were also performed for the BBS, TIN, and WISCI using ICC, SEM, and MDC~95~.

The *validity* domain refers to the degree to which an instrument measures the construct that it purports to measure \[[@B23]\] and is evaluated based on criterion and construct validity.

1\. C*riterion validity* indicates the degree to which the scores of a measurement instrument are an adequate reflection of a standard. The preferred method for estimating criterion validity is correlation coefficient, which should preferably exceed 0.70 \[[@B23]\]. For patients with SCI, the only validated tool for assessing balance is the BBS \[[@B11]\], rendering it the standard tool for determining criterion validity by Spearman correlation coefficient (ρ).

2\. C*onstruct validity* estimates the consistency of measurement instrument scores under the assumption that the instrument measures the construct validity \[[@B23]\], which is calculated as *convergent validity*. Construct validity refers to the degree to which COP parameters correlate with the related scales (BBS and TS~E~)---not with other scales (WISCI and TS~L~) (ie, *appropriateness*). Convergent validity was analyzed using correlation coefficients (R for Pearson coefficient and ρ for Spearman coefficient).

The *responsiveness* domain reflects the sensitivity to changes and is frequently measured by effect size (ES) \[[@B39]\]. ES is based on the data distribution and is the mean difference between values in the first and second assessments, divided by the standard deviation of the baseline values (ie, the values in the first assessment). ES was calculated for patients who participated in at least 2 sessions (17 patients) with regard to clinical and instrumental data.

### Effects of sensory conditions on assessment

The optimal sensory conditions for balance assessment were analyzed by analysis of variance (ANOVA), with vision and support base as the main factors. Further, Pearson correlation between HD and clinical scales was analyzed to determine the influences of HD on balance in SCI subjects.

Statistical analyses were performed using SPSS for Windows (version 9.0, Chicago, IL). Data were considered significant at p \< 0.05. Correlation analyses were performed per Munro's classification \[[@B30]\]: 0.00--0.25: little, if any correlation; 0.26--0.49: low correlation; 0.50--0.69: moderate correlation; 0.70--0.89: high correlation; and 0.90--1.00: very high correlation.

Results
=======

Not all subjects were tested under each sensory condition; subjects with more severe damage were unable to perform the most challenging tasks; CF or CE conditions. Overall, 111 OF-OE, 96 OF-CE, 83 CF-OE, and 73 CF-CE evaluations were performed.

By Spearman correlation analysis, no significant correlations between COP parameter and demographic features (age, height, weight, gender) were observed for any sensory condition (OE, CE, OF, CF) (p \> 0.05).

Measurement properties of COP parameters between test conditions
----------------------------------------------------------------

With regard to reliability*, test-retest reliability* was evaluated by CV for each COP parameter in 3 trials under each condition. The CV of all parameters was minimally affected by sensory condition, indicating their lack of effect on the reliability COP parameters. The most repeatable parameters---those with the lowest CV values---were L, V, and V~LL~. The least repeatable parameter was A, with a mean CV of approximately 50% over all conditions (Table [2](#T2){ref-type="table"}).

###### 

Test-retest reliability of COP parameters by coefficient of variation

  **Parameter**   **Coefficient of Variation \[%\]**                                                   
  --------------- ------------------------------------ --------------- --------------- --------------- ------------------
  **A**           46.4                                 46.7            47.2            42.4            *45.7 (2.2)*
  **L**           13.4                                 13.6            13.8            12.9            ***13.4 (0.3)***
  **SA1**         27.7                                 24.9            22.6            26.0            *25.3 (2.1)*
  **SA2**         27.5                                 26.3            27.8            25.1            *26.7 (1.2)*
  **V**           13.3                                 13.6            13.8            12.9            ***13.4 (0.4)***
  **V**~**LL**~   13.2                                 13.3            12.7            14.2            ***13.4 (0.6)***
  **V**~**AP**~   16.2                                 15.6            18.0            13.3            *15.8 (1.9)*
  **Mean (SD)**   *22.5 (12.3)*                        *22.0 (12.2)*   *22.3 (12.3)*   *21.0 (11.1)*    

The assessment conditions and mean coefficient of variation (CV) for each COP parameter between the 3 trials are reported. The mean values between conditions for each COP parameter (last column) or COP parameters for each condition (last row) are in italic characters. Bold faced numbers in the last column identify the lowest CV values among COP parameters.

The *intrarater reliability* was assessed by ICC for the clinical scales and COP parameters. Of the clinical scales, the BBS had the highest ICC value, whereas the TIN had the lowest. For COP parameters, averaged between sensory conditions, L, V, and V~LL~ had the highest ICC values. In contrast, with regard to sensory conditions, averaged between COP parameters, the OF-OE and OF-CE conditions had the highest ICC values, whereas the CF-CE condition had the lowest ICC (Table [3](#T3){ref-type="table"}). The ICC value of the BBS was the highest of all clinical scales and COP parameters.

###### 

**Intrarater reliability of COP parameters by ICC, SEM, MDC**~**95**~**, and%MDC**

  **Scale**        **ICC**          **SEM**     **MDC**~**95**~   **%MDC**                                                                                                                                                                                                                                
  ---------------- ---------------- ----------- ----------------- ----------- ----------------- --------- ----------------- ---------- ---------------- --------- ----------------- ---------- ---------------- --------- ----------------- ------------ ------------------- --------- ----------------- ------------
  **BBS**          0,97\*\*\*       2,07        5,74              17,2                                                                                                                                                                                                                                    
  **TIN**          0,22             3,54        9,81              58,5                                                                                                                                                                                                                                    
  **TIN**~**E**~   0,87\*\*\*       0,86        2,37              26,3                                                                                                                                                                                                                                    
  **TIN**~**L**~   0,78\*\*\*       1,07        2,97              38,3                                                                                                                                                                                                                                    
  **WISCI**        0,95\*\*         0,73        0,02              13,0                                                                                                                                                                                                                                    
  **COP**          **OF-OE**        **OF-CE**   **CF-OE**         **CF-CE**   ***Mean (sd)***                                                                                                                                                                                                            
  **Parameter**    **ICC**          **SEM**     **MDC**~**95**~   **%MDC**    **ICC**           **SEM**   **MDC**~**95**~   **%MDC**   **ICC**          **SEM**   **MDC**~**95**~   **%MDC**   **ICC**          **SEM**   **MDC**~**95**~   **%MDC**     **ICC**             **SEM**   **MDC**~**95**~   **%MDC**
  **A**            **0,64\*\***     1,67        4,63              141,9       **0,94\*\*\***    2,33      6,46              74,6       **0,92\*\*\***   0,89      2,47              69,0       **0,65\***       5,62      15,58             *116,9*      *0,79 (0,71)*       *2,63*    *7,29*            *100,6*
  **L**            **0,89\*\*\***   37,23       103,2             46,5        **0,92\*\*\***    67, 27    186,46            49,6       **0,92\*\*\***   21,75     60,29             27,2       **0,74\*\***     105,53    292,5             *55,5*       *0,87 (0,08)*       *57,95*   *160,62*          ***44,8***
  **SA1**          **0,85\*\*\***   0,34        0,94              64,7        **0,81\*\*\***    0,49      1,34              72,1       **0,88\*\*\***   0,22      0,62              43,3       **0,79\***       0,69      1,93              *61,0*       *0,83 (0,04)*       *0,44*    *1,21*            *60.2*
  **SA2**          **0,71\*\*\***   0,44        1,21              71,5        **0,89\*\*\***    0,54      1,5               58,0       **0,76\*\***     0,39      1,08              58,9       0,38             6,17      17,09             *796,0*      *0,68 (0,22)*       *1,88*    *5,22*            *246,1*
  **Y**            **0,7**          2,48        6,88              255,5       0,34              5,47      15,17             466,4      0,37             3,36      9,32              413,3      **0,54\***       3,9       10,09             *189,0*      *0,49 (0,16)*       *3,8*     *10,55*           *331,0*
  **X**            **0,54\***       2,87        7,96              1297,2      0,34              2,35      6,52              1552,0     0,01             2,68      7,42              769,5      0,28             3,55      9,83              *18189,0*    *0,29 (0,22)*       *2,86*    *7,93*            *5451,9*
  **V**            **0,89\*\*\***   0,72        2,01              46,3        **0,92\*\*\***    1,31      3,64              49,9       **0,92\*\*\***   0,43      1,18              27,4       0,74\*           2,06      5,7               *55,4*       ***0,87 (1,13)***   *1,13*    *3,13*            ***44,8***
  **V**~**LL**~    **0,89\*\*\***   0,48        1,32              43,9        **0,9\*\*\***     0,73      2,03              47,9       **0,9\*\*\***    0,3       0,82              28,9       **0,83\*\*\***   1,14      3,15              ***49,2***   ***0,88 (0,03)***   *0,66*    *1,83*            ***42,5***
  **V**~**AP**~    **0,82\*\*\***   0,59        1,64              65,0        0,89\*\*\*        1,22      3,39              66, 7      **0,82\*\*\***   0,44      1,21              **45,1**   0,65\*           1,65      4,57              *68,4*       *0,79 (0,1)*        *0,97*    *2,70*            *61,3*
  *Mean*           *0,77*           *5,20*      *14,42*                       *0,77*            *9,08*    *25,17*                      *0,72*           *3,38*    *9,38*                       *0,62*           *14,48*   *40,13*                                                                         
  *(SD)*           *0,13*           *12,05*     *33,39*                       *0,13*            *21,88*   *60,64*                      *0,32*           *6,98*    *19.35*                      *0,19*           *34,20*   *94,80*                                                                         

Significant ICC data are in bold (p \< 0.05:\*, p \< 0.005:\*\*, p \< 0.001:\*\*\*). The mean ICC, SEM, MDC95, and %MDC values between conditions for each COP parameter (last column) or COP parameters for each condition (last row) are in italic characters. The highest mean ICC and %MDC values are in bold faced characters. For abbreviations of COP parameters and sensory conditions, see list of abbreviations.

Due to differences between unit measures, percentage change in MDC~95~ between sessions was used instead of MDC~95~ for the statistical analysis. Of all clinical scales, the BBS and WISCI had the lowest percentage change due to measurement error, and L, V, and V~LL~ had the lowest percentage change due to measurement error of all COP parameters (Table [3](#T3){ref-type="table"}).

*Validity* of the COP parameters was evaluated by correlation analysis with clinical scales, as reported in Table [4](#T4){ref-type="table"}. Of the COP parameters, L, V, V~LL,~ and V~AP~ correlated significantly and systematically with the BBS, TS, and TS~E~. L, V, and V~LL~ also correlated with the TSL but only under the OF-OE/CE conditions, with low R values. Notably, the highest correlations between COP parameters and clinical scales were observed with each parameter in the OF-OE condition. X and Y data did not correlate with the clinical scales (Table [4](#T4){ref-type="table"}).

###### 

Validity of COP parameters

  **Coefficient of correlation**   **Clinical scales**                                                                                          
  -------------------------------- --------------------- ------------------ ----------------- ----------------- ----------------- ------------- ------
  **A**                            **OF-OE**             **- 0.65\*\*\***   **−0.49\*\*\***   **−0.57\*\*\***   **−0.23\***       −0.09         0.41
  **OF-CE**                        **−0.48\*\*\***       **−0.27\*\***      **−0.42\*\*\***   0.07              −0.14             0.28          
  **CF-OE**                        **−0.55\*\*\***       **−0.44\*\*\***    **−0.52\*\*\***   **−0.25\***       −0.08             0.37          
  **CF-CE**                        **−0.31\*\*\***       −0.17              **−0.26\*\*\***   −0.02             −0.16             0.18          
  **L**                            **OF-OE**             **−0.73\*\*\***    **−0.58\*\*\***   **−0.64\*\*\***   **−0.23\***       **−0.21\***   0.48
  **OF-CE**                        **−0.54\*\*\***       **−0.34\*\*\***    **−0.43\*\*\***   0.06              **−0.21\***       0.32          
  **CF-OE**                        **−0.61\*\*\***       **−0.54\*\*\***    **−0.54\*\*\***   **−0.23\***       −0.16             0.42          
  **CF-CE**                        **−0.39\*\*\***       **−0.24\*\*\***    **−0.32\*\*\***   0.01              **−0.39\*\*\***   0.27          
  **SA1**                          **OF-OE**             **−0.68\*\*\***    **−0.53\*\*\***   **−0.61\*\*\***   **−0.30\*\***     −0.11         0.45
  **OF-CE**                        **−0.52\*\*\***       **−0.34\*\*\***    **−0.47\*\*\***   0.02              −0.19             0.31          
  **CF-OE**                        **−0.46\*\*\***       **−0.40\*\*\***    **−0.43\*\*\***   −0.18             −0.09             0.31          
  **CF-CE**                        **−0.26\***           −0.20              **−0.23\***       −0.10             **−0.27\***       0.21          
  **SA2**                          **OF-OE**             **−0.66\*\*\***    **−0.48\*\*\***   **−0.57\*\*\***   **−0.21\***       −0.09         0.40
  **OF-CE**                        **−0.50\*\*\***       **−0.30\*\***      **−0.42\*\*\***   0.02              −0.06             0.26          
  **CF-OE**                        **−0.58\*\*\***       **−0.44\*\*\***    **−0.53\*\*\***   **−0.23\***       −0.05             0.37          
  **CF-CE**                        −0.11                 0.00               −0.11             0.07              −0.06             0.07          
  **Y**                            **OF-OE**             −0.02              −0.08             −0.08             −0.05             **0.22\***    0.09
  **OF-CE**                        −0.13                 −0.13              −0.14             −0.13             0.02              0.11          
  **CF-OE**                        0.02                  −0.12              −0.08             −0.18             **0.29\***        0.14          
  **CF-CE**                        −0.09                 −0.03              −0.04             −0.05             **−0.31\***       0.10          
  **X**                            **OF-OE**             0.00               0.10              0.04              0.01              −0.13         0.06
  **OF-CE**                        −0.01                 0.04               0.01              0.17              −0.11             0.07          
  **CF-OE**                        −0.13                 0.00               −0.10             −0.05             −0.18             0.09          
  **CF-CE**                        −0.17                 −0.15              −0.12             −0.01             −0.14             0.12          
  **V**                            **OF-OE**             **−0.73\*\*\***    **−0.58\*\*\***   **−0.64\*\*\***   **−0.23\***       **−0.22\***   0.48
  **OF-CE**                        **−0.52\*\*\***       **−0.30\*\***      **−0.41\*\*\***   0.10              **−0.24\***       0.31          
  **CF-OE**                        **−0.61\*\*\***       **−0.54\*\*\***    **−0.54\*\*\***   **−0.23\***       −0.16             0.42          
  **CF-CE**                        **−0.39\*\***         **−0.24\***        **−0.32\*\***     0.01              **−0.39\***       0.27          
  **V**~**LL**~                    **OF-OE**             **−0.71\*\*\***    **−0.60\*\*\***   **−0.64\*\*\***   **−0.30\*\***     **−0.22\***   0.50
  **OF-CE**                        **−0.54\*\*\***       **−0.34\*\*\***    **−0.44\*\*\***   0.04              **−0.27\***       0.32          
  **CF-OE**                        **−0.52\*\*\***       **−0.49\*\*\***    **−0.47\*\*\***   **−0.26\***       −0.18             0.38          
  **CF-CE**                        **−0.35\*\***         **−0.24\***        **−0.29\***       −0.07             **−0.39\*\*\***   0.27          
  **V**~**AP**~                    **OF-OE**             **−0.74\*\*\***    **−0.56\*\*\***   **−0.64\*\*\***   −0.18             **−0.20\***   0.47
  **OF-CE**                        **−0.53\*\*\***       **−0.28\***        **−0.40\*\*\***   0.16              −0.19             0.31          
  **CF-OE**                        **−0.69\*\*\***       **−0.56\*\*\***    **−0.59\*\*\***   −0.20             −0.13             0.44          
  **CF-CE**                        **−0.41\*\*\***       **−0.24\***        **−0.32\*\***     0.07              **−0.35\*\***     0.28          

Statistically significant values are in bold (p \< 0.05:\*, p \< 0.005:\*\*, p \< 0.001:\*\*\*). The mean values of absolute values of these coefficients between conditions are reported in last column.

Our evaluation of *criterion validity* by correlation of COP parameters with the BBS determined L, V, V~LL,~ and V~AP~ in the OF-OE condition to be the only parameters with R values over the validity criterion of 0.70. *Convergent validity* was assessed by comparing COP parameters with balance- and nonbalance-related clinical scales. The correlation coefficients of the COP parameters were higher for balance scale scores (BBS, TS, TS~E~) versus locomotion scale scores (TS~L~, WISCI).

The evaluation of *responsiveness,* as measured by ES, is shown in Table [5](#T5){ref-type="table"}. The BBS was the most sensitive clinical scale, with an ES of 0.78. All COP parameters were more sensitive than the clinical scales, with nearly all ES values above 1. Averaging between sensory conditions, L, V, V~LL~, and V~AP~ had the highest ES values. For the sensory conditions, averaged between COP parameters, the OF-OE and CF-CE conditions had the highest ES values (Table [5](#T5){ref-type="table"}).

###### 

Responsiveness of COP parameter assessment

                   **Effect size (ES)**                                                   
  ---------------- ---------------------- --------------- --------------- --------------- -------------------
  **Scale**                                                                               
  **BBS**          **0.78**                                                               
  **TIN**          0.18                                                                   
  **TIN**~**E**~   0.37                                                                   
  **TIN**~**L**~   0.17                                                                   
  **WISCI**        O.07                                                                   
  **Parameter**    **OF-OE**              **OF-CE**       **CF-OE**       **CF-CE**       **Mean (SD)**
  **A**            2.10                   0.81            1.80            1.69            *1.60 (0.55)*
  **L**            1.87                   2.41            1.39            2.96            ***2.16 (0.68)***
  **SA1**          1.28                   1.73            0.58            2.93            *1.63 (0.98)*
  **SA2**          2.72                   0.91            1.25            1.05            *1.48 (0.84)*
  **Y**            1.36                   2.29            1.53            1.43            *1.65 (0.43)*
  **X**            1.52                   1.08            1.11            0.49            *1.05 (0.51)*
  **V**            1.87                   2.41            1.39            2.96            ***2.16 (0.68)***
  **V**~**LL**~    2.79                   3.33            1.13            1.90            ***2.29 (0,97)***
  **V**~**AP**~    2.60                   1.39            2.56            2.88            ***2.36 (0.66)***
  **Mean (SD)**    *2.01 (0.58)*          *1.82 (0.85)*   *1.42 (0.54)*   *2.03 (0.98)*    

Effect size (ES) between 2 sessions for 17 SCI patients. The mean values between conditions for each COP parameter (last column) or between COP parameters for each condition (last row) are in italic characters. The highest ES values among the clinical scales and COP parameters are in bold.

Effects of assessments of sensory conditions
--------------------------------------------

Considering the data above, the effects of sensory conditions were examined, focusing on V---the most sensitive, reliable, and valid COP parameter (Figure [1](#F1){ref-type="fig"}). Overall, foot position had little effect on V, whereas vision affected V significantly. By ANOVA of V values, with vision and support base as the main effects, only vision had a significant effect \[F(1.346) = 76.10; vision: p \< 0.001, support base: p = 0.535, interaction not significant: p = 0.445.\] The COP data were lower for the OE versus CE condition, indicating better balance with vision (Figure [1](#F1){ref-type="fig"}). The lack of a support base effect suggests that the foot conditions have little influence. These data are consistent with the lack of an effect of foot position on COP parameters or scale score correlation data (Table [4](#T4){ref-type="table"}).

![**Effects of conditions on stabilometry.** Histograms of mean COP velocity (V ± standard deviation) versus assessment conditions, depending on support base \[open feet (OF) versus closed feet (CF)\] and vision \[open eyes (OE) versus closed eyes (CE)\].](1743-0003-11-86-1){#F1}

In contrast, in the OF condition, HD was self-selected, and patients used disparate HD conditions. By Pearson correlation analysis between HD and clinical scales, the BBS (ρ = −0.227, p = 0.019), TIN~E~ (ρ = −0.275, p = 0.003), and TIN (ρ = −0.289, p = 0.03) were significant, but TIN~L~ was not (x = −0.112, p = 0.24) (Figure [2](#F2){ref-type="fig"}).

![**Correlation analysis between heel distance and clinical scales.** Correlation between HD and BBS, TIN, TIN~E~, and TIN~LOC~.](1743-0003-11-86-2){#F2}

The importance of the HD in assessing balance with regard to balance recovery was analyzed longitudinally for 17 patients who underwent rehabilitation by considering the HD during the evaluations over time. The mean R was high (R = −0.37, p \< 0.001), indicating a progressive reduction in HD of 3 cm for 150 days in patients who were assessed repeatedly.

Discussion
==========

Reliability, validity, and responsiveness are the key components of determining the suitability of a measurement; these parameters can vary by characteristic of the target population \[[@B30]\]. Our data allow us to define the COP parameters and assessment conditions that are suitable in evaluating postural balance in subjects with incomplete SCI.

**Demographic features** have been claimed to affect the reliability of COP measurements \[[@B6]\]. Although few studies have addressed the effect of gender, all of them agree in disputing sex-related influences on balance, consistent with our findings \[[@B40],[@B41]\]. Height and weight affect COP parameters \[[@B42],[@B43]\]. In our study, we adopted the approach of Salavati et al. \[[@B29]\] in mitigating the effects of height and weight by averaging COP measurements between 3 consecutive trials. Consequently, no correlations between height or weight data and COP parameters were observed.

The influence of age is debated \[[@B40],[@B44]\]. In our cohort, there were no significant correlations between COP parameter and age, supporting the hypothesis that age does not affect SP evaluations in the SCI population. Nevertheless, our study did not specifically aim to determine the effects of aging, and no specific measures were taken to correctly evaluate confounding factors.

Measurement properties of COP parameters between test conditions
----------------------------------------------------------------

*Reliability* can be measured in several ways, of which ICC is the most common in SP studies \[[@B6]\]. Independent of method (CV or ICC) and sensory condition (OF-OE, OF-CE, CF-OE, CF-CE), L, V, and V~LL~ were the most reliable parameters. L is directly (ie, arithmetically) related to V and recording time, and L and V provide the same information, if the recording time has been standardized \[[@B13]\]. Thus, all V and L measures should be considered related, because they are based on the same raw values. The reliability of V in SCI is consistent with findings on V in examining balance in young healthy \[[@B6]\] and old healthy \[[@B27]\] subjects and in patients with orthopedic diseases \[[@B29]\]. Current studies agree that V is the most reliable parameter in assessing balance.

When examining a patient population and possible treatment effects, the significance of a detected change---ie, whether a change is reliable or due to variations in measurement---must be determined \[[@B6]\]. This step is commonly addressed in clinical studies by SEM and MDC~95~\[[@B27],[@B29]\], the latter of which is most frequently used in SCI \[[@B45]-[@B47]\]. Notably, of the COP parameters, V and the related COP parameters L and V~LL~ had the lowest MDC~95~ scores.

As discussed and consistent with Scoltes et al. \[[@B23]\], in addition to reliability, the quality of the instruments' measurements must be established by considering validity and responsiveness---2 parameters that are seldom reported in SP studies. *Validity* is established by reference to the gold standard measurement in this field and by taking into account that the instrument measures the desired construct. BBS is the only balance scale that has been validated specifically for the SCI population \[[@B11]\]. Thus, we analyzed *criterion validity* by correlation analysis between BBS and COP parameters.

When dealing with validity measures, correlation coefficients that exceed 0.70 are considered significant \[[@B23]\]; in our data, V, L, V~LL~, and V~AP~ were the only measures that had correlation coefficients above 0.70. High V validity was also evidenced by the results on convergent validity. Our comparison of correlation coefficients between V and the related COP data and clinical scale---with the same (BBS and TS~E~) or different (TS~L~ and WISCI) constructs---demonstrated high correlation values for BBS and TS~E~ but not for TS~L~ or WISCI. Overall, these findings implicate V as a valid parameter in assessing balance in SCI subjects. Such evaluation methods are unavailable for healthy subjects and other clinically relevant populations. Thus, the validity of V in populations other than SCI patients must be determined.

*Responsiveness* is the ability of an instrument to detect changes in the construct that is measured over time \[[@B48]\]. Whereas validity refers to a single score, responsiveness reflects the validity of a score that has changed \[[@B48]\]. There is an ongoing debate about the ideal method for evaluating responsiveness \[[@B49],[@B50]\]. It has been suggested that all responsiveness measures are measures of longitudinal validity or treatment effects and that, specifically for responsiveness, assessing longitudinal validity should be the preferred method \[[@B49],[@B50]\]. However, no longitudinal validity assessment tool is available for SP. Based on the limitations that were discussed recently by Mokkink et al. \[[@B49]\], we used the most common method, ES, in evaluating responsiveness in SCI subjects. Consistent with previous domains, higher responsiveness was recorded for V and the related L, V~LL~, and V~AP~ measures.

It could be argued that a high intersession ICC score is inconsistent with high intersession responsiveness, unless all subjects undergo similar changes between sessions, as was the case in our cohort---all patients had well-stabilized clinical profiles. Thus, very few changes were expected and recorded in the 2-week intersession period.

Effects of sensory condition assessments
----------------------------------------

In a recent review, Ruhe et al. reported the absence of standardized methods for COP measurements and implicated trial duration, repetition, and visual and foot conditions as critical factors for obtaining reliable COP datasets \[[@B6]\]. Attempts to provide recommendations on the length and number of trials for assessing balance correctly have failed to reach a consensus.

*Trial duration* varies between studies. The recommended trial duration is 90 to 120 s to effect acceptable reliability with correlation coefficients \> 0.75 for most parameters \[[@B6]\]. Nevertheless, early studies reported that a 10--60-sec duration was suitable for obtaining reliable COP data \[[@B51],[@B52]\]. In our study, we did not examine the influence of differences in time on the reliability of COP parameters. The recording time was set to 51.2 per the platform handbook. Although it was short compared with recent recommendations \[[@B6]\], this duration yielded high correlation coefficients (\>0.70) for most parameters.

With regard to *trial repetitions*, there is a tendency to increase trial number to generate more reliable data. Although this pattern might be reasonable when examining young healthy subjects, it becomes impractical when recruiting disabled persons in a clinical setting. Thus, we did not determine trial repetition effects and set a low number of repetitions to permit averaging (3, per Ruhe) \[[@B6]\].

*Vision effects* on the reliability of COP measures have been evaluated in several studies on population-related effects \[[@B6]\]. Recent studies have reported a trend toward higher reliability estimates under the eyes-closed conditions, prompting the recommendation to keep the eyes closed as the best practice. Our study subjects were tested with the eyes open (OE) and closed (CE), although not all subjects were able to perform under the CE condition, indicating the CE condition to be more challenging and discriminating. The significant effect of vision on V values also highlighted its significance.

There were no differences between the 2 visual conditions with regard to the reliability of V. Conversely, vision affected the validity and responsiveness of V indexes. The highest validity was obtained under the OE condition, and the best responsiveness was seen under the CE conditions. The discrepancy between the effects of vision on the validity and responsiveness of V and the lack of an effect of vision on the reliability of V is notable and contrasts the findings of Ruhe \[[@B6]\], suggesting that the eyes-closed condition should be applied, at least in healthy subjects. Validity and responsiveness refer to 2 different domains---ie, validity evaluates the construct that it purports to measure, whereas responsiveness reflects the sensitivity to patient changes. Thus, V can be evaluated with and without vision, at least in SCI subjects.

*Foot position* affects passive stability, decreasing the request of active neural control \[[@B42],[@B53]\], but no consensus exists on the more reliable foot position \[[@B6]\]. Despite this lack of normative data, the best practice guidelines suggest standardization \[[@B6]\]. We tested subjects under 2 feet conditions: CF and OF. In the OF condition, subjects were asked to stand comfortably with their heels apart, and HD was recorded. This setting allowed us to test the closed versus open conditions and determine the effects of HD on COP reliability.

In general, a narrow stance is at least as reliable as a comfortable stance \[[@B6]\], but our findings indicate that foot position (CF or OF) does not affect the reliability of COP parameters. Conversely, the OF condition allowed us to record HD, for which the balance scales had high correlation values. The significance of changes in HD over time suggests that HD can be used to evaluate the effects of recovery and treatment on balance. Overall, OF in the comfortable position with HD recorded appears to be the ideal test condition for SCI subjects, consistent with the recommendations of Chiari \[[@B42]\] and Yoon \[[@B40]\] for healthy subjects.

Based on the limitations above, taking into account the V data, OF-OE is the most valid condition and OF-CE is the most responsive condition, suggesting that both should be implemented in testing SCI subjects.

The comparison of reliability and responsiveness between the V value of COPs in the OF-OE and OF-CE conditions and the balance scales merits further examination. To facilitate the comparison between the V and balance scale results, the ICC, %MDC, and ES data are presented in Figure [3](#F3){ref-type="fig"}. Because BBS is the reference standard, the V results only approximate the BBS ICC data. Yet, greater changes in V versus BBS in patient balance are required to obtain improvements that are not due to instrument error.

![**Comparison of ICC,%MDC, and ES results between balance scales and V data for OF-OE and OF-CE conditions.**](1743-0003-11-86-3){#F3}

The most notable comparison concerns responsiveness. V ES, particularly in the OF-CE condition, was superior to all clinical scales. The difference between ES values was 0.78 for BBS and 2.41 for V in the OF-CE condition. Thus, the proposed SP protocol significantly increases the ability to detect changes in the balance of SCI subjects compared with BBS.

Our study did not specifically evaluate the reliability, validity, and effectiveness of SP parameters for evaluating recovery after SCI. This aspect must be addressed in a devoted study, with repeated measures conducted during rehabilitation and balance recovery.

Limitations: Instructions to the patients, time of testing, and trial repetitions were present and were not tested experimentally. The reliability, validity, and effectiveness of COP parameters in assessing stabilometric platform were not been tested in healthy control subjects' group. The psychometric properties of COP measurements in healthy individuals have been examined in several studies \[[@B6]\], particularly in the elderly \[[@B27],[@B44]\]. Nevertheless, the assessment of detailed data on healthy controls should be included in a devoted study.

Conclusion
==========

To obtain a reliable and valid instrument for assessing balance by SP in SCI patients, COP V data must be acquired, based on OF-OE and OF-CE conditions, reporting heel distance values for OF conditions.
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